Affinity Asset Advisors, LLC

Holdings History for Lexeo Therapeutics, Inc. - Common Stock ($0.0001 par value) (the "Shares") (LXEO)

Symbol: LXEO on Nasdaq
Investment type: Equity / Common Stock ($0.0001 par value) (the "Shares")
Latest Disclosed Shares Owned: 5,217,660 shares
Security Ownership %: 7.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Affinity Asset Advisors, LLC ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO)

29 Jan 2026 - Affinity Asset Advisors, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,217,660 shares of Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO). This represents 7.1% ownership of the company. In their previous filing dated 04 Jun 2025, Affinity Asset Advisors, LLC had reported owning 4,252,005 shares, indicating an increase of +23%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Affinity Asset Advisors, LLC	7.1%	-8.1%	$51,813,451	5,217,660	+965,655	+23%	$9.93	13G/A	22 Jan 2026	29 Jan 2026, 19:58
Affinity Healthcare Fund, LP	7.8%		$12,713,495	4,252,005			$2.99	13G	28 May 2025	04 Jun 2025, 16:04

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.3%	-0.48%	$31,776,000	3,200,000	-670,527	-17%	$9.93	Q4 2025
30 Sep 2025	2.4%	+0.17%	$25,700,299	3,870,527	+281,172	+7.8%	$6.64	Q3 2025
30 Jun 2025	2.1%	+1.3%	$14,429,207	3,589,355	+2,108,474	+142%	$4.02	Q2 2025
31 Mar 2025	0.8%	+0.8%	$5,138,657	1,480,881	+1,480,881	NEW	$3.47	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.